Search

Your search keyword '"Tybjaerg-Hansen, Anne"' showing total 916 results

Search Constraints

Start Over You searched for: Author "Tybjaerg-Hansen, Anne" Remove constraint Author: "Tybjaerg-Hansen, Anne" Language english Remove constraint Language: english
916 results on '"Tybjaerg-Hansen, Anne"'

Search Results

2. Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

5. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

6. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

8. Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

11. Stroke genetics informs drug discovery and risk prediction across ancestries

13. New insights into the genetic etiology of Alzheimer’s disease and related dementias

14. ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma

15. Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile

16. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

22. Epigenetic Regulation of F2RL3 Associates with Myocardial Infarction and Platelet Function

24. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries

26. Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome

28. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

34. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

36. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

38. Polygenic risk scores for cardiovascular risk prediction: moving towards implementation into clinical practice?

42. Neutrophil counts and cardiovascular disease.

43. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life.

44. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.

45. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

46. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

49. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Catalog

Books, media, physical & digital resources